Physician

Tod Alan Mcmillan, M.D.

According to 2025 Medicare claims, Tod Mcmillan, M.D. (NPI: 1023014347) practices ophthalmology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is SOUTHEASTERN RETINA ASSOCIATES, P.C. (NPI: 1932200664; TIN: 621094813) and primary practice location at 37909-2686.

Mcmillan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 573 traditional Medicare patients, billed 35,100 HCPCS/CPT codes, and received $2,846,652 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 696 prescription claims across 164 beneficiaries totaling $24,266 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $4,335,185 to $2,846,652. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.5M2015 Medicare payment: $4,335,185 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,465,071 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,130,124 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,894,595 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,579,613 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,392,479 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,407,674 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,995,720 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,573,227 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,846,652 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201581519,594$4,335,185
201684819,113$4,465,071
201778917,368$4,130,124
201872516,300$3,894,595
201970715,090$3,579,613
202059413,986$3,392,479
202156214,369$3,407,674
202257414,503$2,995,720
202360924,136$2,573,227
202457335,100$2,846,652

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$33K2015 Drug cost: $22,934 (USD; Tot_Drug_Cst)2016 Drug cost: $25,044 (USD; Tot_Drug_Cst)2017 Drug cost: $28,813 (USD; Tot_Drug_Cst)2018 Drug cost: $29,399 (USD; Tot_Drug_Cst)2019 Drug cost: $28,865 (USD; Tot_Drug_Cst)2020 Drug cost: $29,419 (USD; Tot_Drug_Cst)2021 Drug cost: $32,515 (USD; Tot_Drug_Cst)2022 Drug cost: $22,914 (USD; Tot_Drug_Cst)2023 Drug cost: $26,805 (USD; Tot_Drug_Cst)2024 Drug cost: $24,266 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015103356$22,934
2016110409$25,044
2017116458$28,813
2018120483$29,399
2019107450$28,865
2020120530$29,419
2021140522$32,515
2022146534$22,914
2023138571$26,805
2024164696$24,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2131,457$97
92014Established patient complete exam of visual system293347$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more243340$66
92134Imaging of retina4321,693$29
92250Photography of the retina272334$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1777,100$10,231
Atropine SulfateAtropine Sulfate833,275$2,886
Brimonidine TartrateBrimonidine Tartrate311,689$1,454
MoxifloxacinMoxifloxacin Hcl801,173$1,451
Ketorolac TromethamineKetorolac Tromethamine431,236$1,340

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$17Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tod Alan Mcmillan, M.D.?

Tedicare shows public-source Medicare data for Tod Alan Mcmillan, M.D. (NPI 1023014347), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tod Alan Mcmillan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tod Alan Mcmillan, M.D.?

Tod Alan Mcmillan, M.D. is linked to SOUTHEASTERN RETINA ASSOCIATES, P.C. (billing NPI 1932200664) in the available physician profile data.

Does Tod Alan Mcmillan, M.D. have Open Payments data?

Tod Alan Mcmillan, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.